Kolexia
Serrero Melanie Gastro-entérologie
Serrero Melanie
Gastro-entérologie
Hôpital Nord Marseille
Marseille, France
126 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Rectocolite hémorragique Colite Fistule Fistule rectale Abcès Nécrose Obésité

Collaborateurs

Voir plus
Peyrin-Biroulet Laurent
Peyrin-Biroulet Laurent
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Laharie David
Laharie David
Hôpital Haut-lévêque, Pessac, France
Fumery Mathurin
Fumery Mathurin
Centre Hospitalier D'Amiens Salouël Site Sud, Salouël, France
Amiot Aurelien
Amiot Aurelien
Hôpital Henri Mondor, Créteil, France

Industries

Voir plus
Abbvie
47 collaboration(s)
Dernière en 2023
Janssen
40 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
22 collaboration(s)
Dernière en 2023
Galapagos SASU
8 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   27 janvier 2024
TRENCH 1: TRansmural hEaliNg Definition in CroHn's Disease - The TRENCH1 Study
Essai Clinique (Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives)   15 janvier 2024
EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis : A Double Blinded Randomized Clinical Trial
Essai Clinique (CHU Rennes)   20 novembre 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.
Journal of Crohn's & colitis   20 octobre 2023
The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics.
Frontiers in immunology   28 août 2023
Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID.
Clinical and translational gastroenterology   01 août 2023
CONTROL: An Open-label Randomized Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating adaLimumab: The CONTROL Trial
Essai Clinique (Abbvie)   30 mai 2023
Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   26 mai 2023
POP-REMIND: Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group
Essai Clinique (Hôpital Saint-Louis)   11 avril 2023
Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 Study.
Inflammatory bowel diseases   05 avril 2023